Drugs / brimonidine/timolol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00332345 | Jul → Aug 1999 | ocular hypertension | Allergan | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | brimonidine/timolol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00332345 ↗ |